EP1248788A1 - Synthesis of isosorbide mononitrate - Google Patents
Synthesis of isosorbide mononitrateInfo
- Publication number
- EP1248788A1 EP1248788A1 EP00985697A EP00985697A EP1248788A1 EP 1248788 A1 EP1248788 A1 EP 1248788A1 EP 00985697 A EP00985697 A EP 00985697A EP 00985697 A EP00985697 A EP 00985697A EP 1248788 A1 EP1248788 A1 EP 1248788A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- alkali metal
- isosorbide
- groups
- alkyl
- transition metal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 title description 50
- 229960003827 isosorbide mononitrate Drugs 0.000 title description 50
- 230000015572 biosynthetic process Effects 0.000 title description 10
- 238000003786 synthesis reaction Methods 0.000 title description 7
- 238000000034 method Methods 0.000 claims abstract description 56
- 239000003054 catalyst Substances 0.000 claims abstract description 50
- 150000001875 compounds Chemical class 0.000 claims abstract description 29
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 28
- 229910052723 transition metal Inorganic materials 0.000 claims abstract description 25
- 150000003624 transition metals Chemical class 0.000 claims abstract description 25
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 21
- 239000001257 hydrogen Substances 0.000 claims abstract description 21
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229910052742 iron Inorganic materials 0.000 claims abstract description 14
- 229910017052 cobalt Inorganic materials 0.000 claims abstract description 12
- 239000010941 cobalt Substances 0.000 claims abstract description 12
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims abstract description 12
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 9
- 229910052697 platinum Inorganic materials 0.000 claims abstract description 6
- 125000003118 aryl group Chemical group 0.000 claims abstract description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 4
- 125000000923 (C1-C30) alkyl group Chemical group 0.000 claims abstract description 3
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 3
- 125000004104 aryloxy group Chemical group 0.000 claims abstract description 3
- 125000004429 atom Chemical group 0.000 claims abstract description 3
- 125000004181 carboxyalkyl group Chemical group 0.000 claims abstract description 3
- 125000005352 carboxycycloalkyl group Chemical group 0.000 claims abstract description 3
- 125000000392 cycloalkenyl group Chemical group 0.000 claims abstract description 3
- 125000000000 cycloalkoxy group Chemical group 0.000 claims abstract description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 3
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract description 3
- 125000005553 heteroaryloxy group Chemical group 0.000 claims abstract description 3
- 125000005842 heteroatom Chemical group 0.000 claims abstract description 3
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 3
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 117
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 87
- -1 sulphonate ester Chemical class 0.000 claims description 56
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 54
- 230000009467 reduction Effects 0.000 claims description 42
- 238000006243 chemical reaction Methods 0.000 claims description 38
- 229910052783 alkali metal Inorganic materials 0.000 claims description 30
- 239000002904 solvent Substances 0.000 claims description 25
- 125000000217 alkyl group Chemical group 0.000 claims description 20
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 19
- 150000004678 hydrides Chemical class 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 19
- 229910052708 sodium Inorganic materials 0.000 claims description 19
- 239000011734 sodium Substances 0.000 claims description 19
- 150000001340 alkali metals Chemical class 0.000 claims description 18
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 14
- 229910052700 potassium Inorganic materials 0.000 claims description 14
- 239000011591 potassium Substances 0.000 claims description 14
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 13
- 229910052744 lithium Inorganic materials 0.000 claims description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 125000004122 cyclic group Chemical group 0.000 claims description 12
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 claims description 11
- 229910003446 platinum oxide Inorganic materials 0.000 claims description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 7
- 239000012298 atmosphere Substances 0.000 claims description 7
- 229910000102 alkali metal hydride Inorganic materials 0.000 claims description 3
- 150000008046 alkali metal hydrides Chemical class 0.000 claims description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000000739 C2-C30 alkenyl group Chemical group 0.000 claims description 2
- 229940064734 aminobenzoate Drugs 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 150000003568 thioethers Chemical class 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 abstract description 2
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 62
- 229960000201 isosorbide dinitrate Drugs 0.000 description 53
- 229910000033 sodium borohydride Inorganic materials 0.000 description 46
- 239000012279 sodium borohydride Substances 0.000 description 46
- 238000006722 reduction reaction Methods 0.000 description 45
- KLDXJTOLSGUMSJ-JGWLITMVSA-N Isosorbide Chemical compound O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-JGWLITMVSA-N 0.000 description 30
- 229960002479 isosorbide Drugs 0.000 description 24
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- 238000004817 gas chromatography Methods 0.000 description 21
- KMHSUNDEGHRBNV-UHFFFAOYSA-N 2,4-dichloropyrimidine-5-carbonitrile Chemical compound ClC1=NC=C(C#N)C(Cl)=N1 KMHSUNDEGHRBNV-UHFFFAOYSA-N 0.000 description 20
- 230000008569 process Effects 0.000 description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 230000002829 reductive effect Effects 0.000 description 15
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- JYWNYMJKURVPFH-UHFFFAOYSA-N N-gamma-Acetyl-N-2-Formyl-5-Methoxykynurenamine Chemical compound COC1=CC=C(NC=O)C(C(=O)CCNC(C)=O)=C1 JYWNYMJKURVPFH-UHFFFAOYSA-N 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 9
- 238000007792 addition Methods 0.000 description 9
- MPMSMUBQXQALQI-UHFFFAOYSA-N cobalt phthalocyanine Chemical compound [Co+2].C12=CC=CC=C2C(N=C2[N-]C(C3=CC=CC=C32)=N2)=NC1=NC([C]1C=CC=CC1=1)=NC=1N=C1[C]3C=CC=CC3=C2[N-]1 MPMSMUBQXQALQI-UHFFFAOYSA-N 0.000 description 9
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- 238000011944 chemoselective reduction Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- 238000000921 elemental analysis Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000012258 stirred mixture Substances 0.000 description 4
- KLDXJTOLSGUMSJ-KVTDHHQDSA-N (3r,3ar,6r,6ar)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3,6-diol Chemical compound O[C@@H]1CO[C@@H]2[C@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-KVTDHHQDSA-N 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000007868 Raney catalyst Substances 0.000 description 3
- 229910000564 Raney nickel Inorganic materials 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 3
- 238000005804 alkylation reaction Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 238000011946 reduction process Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000011877 solvent mixture Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229910052720 vanadium Inorganic materials 0.000 description 3
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 3
- KLDXJTOLSGUMSJ-UNTFVMJOSA-N (3s,3ar,6s,6ar)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3,6-diol Chemical compound O[C@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-UNTFVMJOSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 241000589540 Pseudomonas fluorescens Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000012967 coordination catalyst Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical class OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 238000006396 nitration reaction Methods 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- KLDXJTOLSGUMSJ-UHFFFAOYSA-N 2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3,6-diol Chemical compound OC1COC2C(O)COC21 KLDXJTOLSGUMSJ-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 241000235555 Cunninghamella Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- VBQDSLGFSUGBBE-UHFFFAOYSA-N benzyl(triethyl)azanium Chemical compound CC[N+](CC)(CC)CC1=CC=CC=C1 VBQDSLGFSUGBBE-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910000464 lead oxide Inorganic materials 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003791 organic solvent mixture Substances 0.000 description 1
- YEXPOXQUZXUXJW-UHFFFAOYSA-N oxolead Chemical compound [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000021309 simple sugar Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- CXVCSRUYMINUSF-UHFFFAOYSA-N tetrathiomolybdate(2-) Chemical compound [S-][Mo]([S-])(=S)=S CXVCSRUYMINUSF-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Definitions
- This invention relates to the synthesis of chemical compounds, in particular the synthesis of isosorbide-5- mononitrate and substituted analogues thereof. More specifically, the invention relates to the preparation of isosorbide-5-mononitrate via selective chemical reduction of isosorbide dinitrate.
- Isosorbide (1, 4 : 3, 6-dianhydro-D-glucitol) is one of the hexitol class of bicylic heterocyles derived from simple sugars, which in recent years has attracted increasing interest, particularly as regards its biological activity. This growing importance particularly of certain analogues of isosorbide is attributable to the reactivity of the hydroxyl groups, which as shown in the structural formula of isosorbide below are, relative to the ring juncture, exo at the 2-position and endo at the 5-position:
- Isosorbide-5-mononitrate is currently the most commercially important analogue of isosorbide, which is an important vasodilator useful in cardiac treatment, for example for treating angina.
- This method selectively esterifies isosorbide with carboxylic acid derivatives in the presence of 4-dimethylaminopyridine (DMAP) .
- DMAP 4-dimethylaminopyridine
- the yields for the functionalised isosorbide were of the order of 68 to 85% of the 2-protected diol.
- This approach is an example of the utilisation of the sterically unhindered 2-exo hydroxyl group which is esterified in preference to the more sterically crowded 5-en o moiety. The process however suffers from problems relating to the expense and toxicity of the requests used.
- Chandrasekaran et al disclose a process involving che o- selective reduction of isosorbide dinitrate to its 5- ononitrate in a 70% yield using benzyltriethylammonium tetrathiomolybdate.
- a corresponding process was achieved using a titanium borohydride complex which gave isosorbide-5-mononitrate in a 57% yield.
- the cost of such reduction complexes makes such processes unfeasible on anything other than a laboratory scale.
- the present invention has been devised and involves selective chemical reduction of isosorbide-2, 5-dinitrate using particular reducing systems hitherto not disclosed for this purpose.
- the present invention provides a method of synthesising a compound of the following formula (1) ,
- each of R 1 and R 2 is independently selected from H or optionally substituted straight or branched chain C 1 -C 30 alkyl, C x -C 30 carboxyalkyl, C 1 -C 30 sulphoxyalkyl, C 1 -C 30 alkoxy, C 3 -C 30 cycloalkyl, C 3 -C 30 carboxycycloalkyl, C 3 -C 30 sulphoxycycloalkyl, C 3 -C 30 cycloalkoxy, heterocyclic, carboxyheterocyclic, sulphoxyheterocyclic, oxyheterocyclic, C 3 -C 30 cycloalkenyl, carboxycycloalkenyl, sulphoxycycloalkenyl or cycloalkenoxy, C 8 -C 30 cycloalkynyl, carboxycycloalkynyl, sulphoxycycloalkynyl or cycloalkynoxy, C 2 -C 30 alkynyl,
- a reducing system effective to selectively reduce the compound of formula (2) at the 2-position to produce the compound of formula (1) , wherein the reducing system is selected from (i) hydrogen in the presence of a platinum- containing catalyst, or (ii) a hydride source in the presence of a transition metal phthalocyanine or polyphthalocyanine in which the transition metal is iron and/or cobalt.
- the invention provides a compound according to formula (1) as defined above as or when produced by the method of the first aspect of the invention.
- the invention further provides, in a third aspect, the use of a reducing system selected from (i) hydrogen in the presence of a platinum-containing catalyst, or (ii) a hydride source in the presence of a transition metal phthalocyanine or polyphthalocyanine in which the transition metal is iron and/or cobalt for effecting reduction selectively at the 2-position of a compound according to formula (2) to form a compound of formula (1) .
- a reducing system selected from (i) hydrogen in the presence of a platinum-containing catalyst, or (ii) a hydride source in the presence of a transition metal phthalocyanine or polyphthalocyanine in which the transition metal is iron and/or cobalt for effecting reduction selectively at the 2-position of a compound according to formula (2) to form a compound of formula (1) .
- the compound according to formula (1) as defined above is preferably isosorbide-5- mononitrate, i.e. that compound in which R 1 and R 2 are both hydrogen.
- the isosorbide dinitrate of formula (2) may be prepared by any known synthetic route and is available commercially. By way of example, it may be prepared by direct nitration or isosorbide in a mixture of nitric acid, acetic anhydride and acetic acid at a temperature of 5-10°C, as taught by Jackson & Hayward, Can. J. Che ., 38 (1960), 496, 49T, 500.
- the reducing system which is used to reduce the 2, 5-dinitrate compound of formula (2) selectively (or, more correctly, preferentially) at the 2- position is selected from (i) hydrogen in the presence of a platinum-containing catalyst, or (ii) a hydride source in the presence of a transitional metal phthalocyanine or polyphthalocyanine, which transition metal is selected from iron or cobalt.
- a transitional metal phthalocyanine or polyphthalocyanine which transition metal is selected from iron or cobalt.
- this can be phthalocyanine polymer co plexed with either or both of iron or cobalt.
- the catalyst is preferably platinum oxide.
- the reaction is preferably carried out by reacting a solution of the dinitrate compound with hydrogen gas, e.g. by stirring under a hydrogen atmosphere at e.g. room temperature and at a suitable pressure.
- the pressure of the hydrogen atmosphere is preferably in the range of from about 5 to about 300 psi and the reaction time is preferably from about 60 to about 600 minutes .
- the reaction may be carried out further in the presence of a not easily oxidisable coordinating metal salt, in order to assist the selectivity of the reduction process towards the 2-position on the isosorbide moiety.
- a suitable such coordinating metal salt is nickel (II) chloride. It may however by desirable not to use such a material in the carrying out of the process in view of the toxicity implications of nickel, and indeed it is an advantage of the reducing systems according to the invention fhat such a selector, as used for example in EP-A-0201067, is not necessary for achieving adequate yields of the decided 5-mononitrate product.
- the not easily oxidisable coordinating metal salt as a selector may preferably be used in an amount of from about 0.5% to about 50% molar equivalent (based on the amount of compound of formula (2)) .
- the hydride source acts as the principal reducing agent, with the transition metal (iron or cobalt) phthalocyanine (or polyphthalocyanine) acting as a coordination catalyst to drive the reduction selectively to the 2-position.
- Zinc powder used in the following procedure was activated by stirring with 1% hydrochloric acid, washing with water, ethanol, acetone and diethyl ether, then dried and immediately used in the following process.
- the hydride source may be selected from any of the following: alkali metal tetrahydroborates (e.g. sodium, potassium or lithium tetrahydroborates) , alkali metal hydrides (such as sodium, potassium or lithium hydrides) , alkali metal tetrahydridoaluminates (such as those of lithium or sodium) , alkali metal alkyl borohydrides (where the alkali metal is lithium, sodium or potassium, and up to three alkyl groups can be present, each alkyl group comprising branched chain, linear or cyclic carbon groups of up to 20 carbon atoms)), alkali metal alkoxy borohydrides (where the alkali metal is lithium, sodium or potassium, and up to three alkoxy groups can be present, each alkoxy group comprising branched chain, linear or cyclic carbon groups of up to 20 carbon atoms)), alkali metal alkyl hydridoaluminates (where the alkali metal is lithium, sodium or potassium
- the catalyst is preferably selected from iron or cobalt phthalocyanine, which together with the hydride source (preferably sodium tetrahydroborate) give excellent yields and degrees of selectivity in the conversion of isosorbide dinitrate to isosorbide-5-mononitrate.
- the hydride source preferably sodium tetrahydroborate
- the amount of hydride source (especially sodium tetrahydroborate) used in the process of the invention may typically be from about 1 to about 10 molar equivalents, more preferably from about 1.5 to about 6 molar equivalents (based on the amount of compound of formula (2)) .
- the amount of the transition metal phthalocyanine catalyst will typically be from about 1 to about 10% molar equivalents (on the same basis) .
- the reaction is preferably carried out in an organic solvent.
- Methanol is a preferred organic solvent, although other suitable organic solvents may include higher aliphatic alcohols, chloroform, THF, dichloromethane, t-butanol, acetone, t- butylmethylether, acetonitrile or dimethylformamide. Any combination of one or more organic solvent components may be used. However, it has been found to be particularly preferred to use a solvent system comprising a mixture of organic solvents especially dichloromethane/methanol or dichloromethane/ethanol.
- SUch organic solvent mixtures are advantageous because they permit control over the vigour of the reaction between the isosorbide dinitrate and the hydride source/transition metal pythalocyanine catalyst, whilst the methanol component assists in the dissolution of the sodium tetrahydro borate allowing better reaction with the dissolved isosorbide dinitrate.
- the dichloromethane/methanol solvent mixture is somewhat preferred over the dichloromethane/ethanol system, because of the lower solubility of sodium tetrahydroborate in ethanol as compared within methanol. It is possible, however, that the solvent reaction medium may also contain an amount of water, e.g. in an amount of up to about 20% by weight of the total amount of solvent.
- a Gallenkamp (UK) electrothermal melting point unit was used according to the standard procedure.
- Isosorbide-2-mononitrate (0.5g, 2. ⁇ mmol) was dissolved in ethanol (50ml) . Platinum ' 'oxide (20mg) was added and the reaction mixture stirred at room temperature. The system was de-aerated and then placed under an atmosphere of hydrogen (14 psi pressure) . The reaction was monitored by HPLC for the formation of reduction products and the amount of residual isosorbide-2-mononitrate remaining in the reaction mixture.
- This Example therefore demonstrates the preferential reduction of isosorbide-2, 5-dinitrate at the 2-position rather than at the 5-position.
- This example demonstrates the use of hydrogen gas in the presence of platinum oxide catalyst as the reducing system in the method according to the invention.
- Isosorbide-2, 5-dinitrate (2g, 8.48mmol) was dissolved in methanol (30ml) .
- platinum oxide (25mg) was added to this solution and the air was removed using a vacuum pump and replaced with an atmosphere of hydrogen is 14 p.s.i pressure) .
- the reaction mixture was stirred at room temperature.
- the presence of reaction components was monitored by GC. The results are shown in Graph 2 below.
- This example demonstrates the use of H 2 /Pt0 2 as the reducing system, but additionally in the presence of nickel chloride as a selector to further drive the reduction towards the 2-position.
- Graph 3 Chemoselective reduction of isosorbide-2, 5- dinitrate as H 2 /PtO? and nickel chloride.
- Isosorbide-2, 5-dinitrate (4g, 16.94mmol) was added to methanol (80ml) and stirred at room temperature.
- Platinum oxide (50mg) was added and the system was de-aerated using a vacuum pump. The atmosphere was replaced with hydrogen gas (14 psi pressure) and the system was monitored by GC. After three hours the reaction was terminated by the removal of hydrogen and the catalyst was vacuum filtered over a bed of Celite.
- Example 5 Scale-up example using H?/PtO ? as the reducing system
- Example 4 In order to demonstrate the ability of the laboratory scale reductions exemplified above to be scaled up, the method of Example 4 was scaled up by a factor of 15.
- Isosorbide-2, 5-dinitrate 60g, 0.254mol was dissolved in methanol (1200ml) and platinum oxide (750mg) was added and the vessel purged with hydrogen (14 psi pressure) . Once fully purged, the reaction mixture was stirred at room temperature and the pressure regulated to the desired level. The procedure was repeated for different H 2 pressures in order to further illustrate the effect of pressure on the efficiency of the reduction reaction. The experiment was repeated 5 times, using pressures of 20, 50, 70, 120 and 300 psi. The results are shown in Graph 4 below.
- Example 6 Selective reduction of isosorbide dinitrate using sodium tetrahydroborate/iron phthalocyanine.
- This example demonstrates the use of sodium tetrahydroborate/iron phthalocyanine as the reducing system in the production of isosorbide-5-mononitrate from isosorbide dinitrate in accordance with the invention.
- Isosorbide dinitrate (0.500g, 2.12mmol) was dissolved in methanol (20ml) and to this solution was added iron phthalocyanine (0.075g, 0.132mmol). To this suspension was added, with stirring at room temperature, sodium tetrahydroborate (0.160g, 4.23mmol). After an initial vigorous reaction the solution was acidified with hydrochloric acid (2M HCl, 10ml), upon which the catalyst became insoluble. The solution was then neutralised by addition of sodium hydroxide (2M NaOH) . The catalyst was removed by filtration and the reduction products were extracted with dichloromethane (30ml xlO) .
- Isosorbide-5- mononitrate was isolated by column chromatography (silica, acetonitrile 15% in dichloromethane) . After filtration of the catalyst, it was reused in the process as detailed above. In one case the catalyst was used three times. The yield of isosorbide-5-mononitrate recovered from each use of the catalyst is shown in Table 1 below.
- Example 7 Selective reduction of isosorbide dinitrate using sodium tetrahydroborate/cobalt phthalocyanine.
- Example 8 Variability of cobalt phthalocyanine and sodium tetrahydroborate levels in selective reduction of isosorbide dinitrate
- cobalt phthalocyanine catalyst loading (% w/w relative to isosorbide) and sodium tetrahydroborate molar equivalent levels were systematically varied.
- a first set of runs details the variance in isolated yield of isosorbide-5-mononitrate as the levels of cobalt phthalocyanine catalyst were varied, while holding the levels of sodium tetrahydroborate used at a constant 6 molar equivalents (relative to the level of isosorbide used) .
- the method used was as follows:
- Isosorbide dinitrate (0.5g; 2.12mmol) was dissolved in methanol (20ml) and cobalt phthalocyanine was added
- Isosorbide dinitrate (lg; 4.24mmol) was dissolved in methanol (200ml). Potassium hydroxide solution (0.25mol; 100ml) was added and the system was stirred at room temperature. Raney nickel (2.0g) was added to the stirred 35 . solution, portionwise, over one hour and the reaction was monitored by GC. Analysis of the mixture after addition showed >95% isosorbide content, indicating that large-scale overreduction had occurred.
- Isosorbide dinitrate 500mg; 2.12mmol was dissolved in methanol (20ml) , and to this solution was added 75mg of the metal phthalocyanine catalyst (where the metal was zinc, magnesium, sodium or vanadium) . While stirring the suspension at room temperature, sodium tetrahydroborate (l ⁇ Or ⁇ g; 4.23mmol) was added and after an initial vigorous reaction hydrochloric acid (2M; 10ml) was added, at which point the catalyst became insoluble in the reaction mixture. The solution was neutralised by the addition of 2M sodium hydroxide solution, after which the catalyst was removed by filtration and the reduction products extracted with 10x30ml portions of dichloromethane. The dichloromethane was evaporated under reduced pressure and the residues analysed by GC. The analysis showed >95% unreacted isosorbide dinitrate.
- Isosorbide dinitrate (l.Og; 4.24mmol) was dissolved in a mixture of 10ml dichloromethane and 2ml methanol,. and sodium tetrahydroborate (0.32g; 8.46mmol) was added to the stirred mixture. The mixture was stirred for a further 1 hour, then acidified with approximately 10ml of 2N HC1 solution (effervescent reaction) followed by neutralisation with 2N sodium hydroxide. The organic layer was water washed and stripped under reduced pressure. GC analysis of the residue indicated 96.85% unreacted isosorbide dinitrate.
- Isosorbide dinitrate (5g; 21.2mmol) was stirred in lOOmls of ethanol and the mixture was cooled to -10°C under nitrogen for about 20 minutes, then zinc powder (3g; 45.9mmol; pretreated as above) and acetic acid (2ml; 6mmol) were added. After 7hrs a further 1ml of acetic acid was added. After a further 5hrs isosorbide dinitrate (3g; 13mmol) , zinc powder (3 ⁇ j; 45.9mmol; pretreated as above) and acetic acid (2ml; 46mmol) were sequentially added. The mixture was allowed to stir for a further 10 hrs before filtration and evaporation under reduced pressure.
- Example 11 This example demonstrates the use of preferred solvent mixtures for optimising the selective reduction of isosorbide dinitrate to isosorbide-5-mononitrate using sodium tetrahydroborate and iron pythalocyanine catalyst.
- Isosorbide dinitrate (lg; 4.23mmol) was dissolved in 2.5mls of acetonitrile, and this solution was added slowly to a cold (10°C) stirred solution of 0.32g (8.46mmol) of sodium tetrahydroborate and 0.15g (0.264mmol) of iron phthalocyanine in 6mls of ethanol. The resultant mixture was filtered, evaporated to dryness, then analysed by GC. The GC data (run 3 of Table 5 below) indicated essentially no remaining isosorbide dinitrate, with 84.14% isosorbide- 5-mononitrate, and 13.86% isosorbide (as a result of overreduction) . The run was repeated on a 5g isosorbide dinitrate scale, and the results were again very consistent with the initial run (run 4 of Table 5 below) .
- Example 11 The preparative methodology used was as described in Example 11 above.
- the 2 molar equivalents of sodium tetrahydroborate (as outlined in Examples 5-7 of Table 5 above) was reduced to 1.5 molar equivalents (run 1 of Table 6 below) .
- the GC analysis of the reaction mixture indicates that 1.5 molar equivalents of sodium tetrahydroborate is extremely undesirable for the dichloromethane/ethanol system as the reaction had only gone to 37.7% completion, with 61.85% unreacted isosorbide dinitrate remaining.
- the preparative methodology used was as described in Example 11 above.
- the 2 molar equivalents of sodium tetrahydroborate (as outlined in Example 8 of Table 5 above) was reduced to 1.75 aid 1.5 molar equivalents (run 2 and 3 respectively of Table 6 below) .
- the GC analyses indicates only a slight reduction in isosorbide-5- mononitrate content relative to the case where 2 molar equivalents of sodium tetrahydroborate were used, although it may have been the case for the use of 1.5 molar equivalents of sodium tetrahydroborate that the reaction might have progressed to give a higher overall yield of isosorbide-5-mononitrate if allowed to stir for a further hour after addition of the alcohol.
- This example describes variation in the molar quantities of iron phthalocyanine catalyst used for both solvent combinations (dichloromethane/ethanol and dichloromethane/methanol ) .
- the preparative methodology used was as described in Example 11 above.
- the 0.0623 molar equivalents of iron phthalocyanine catalyst (as outlined in Examples 5-7 of Table 5 above) was reduced by 50% to 0.0312 molar equivalents (run 1 of Table 7 below) , while maintaining the sodium tetrahydroborate level at 2 molar equivalents (as for Examples 5-7 of Table 5 above) .
- the GC analysis of the reaction mixture indicates that 0.0312 molar equivalents of iron phthalocyanine catalyst is extremely undesirable for the dichloromethane/ethanol system as the reaction had only gone to 26.9% completion, with 70.27% unreacted isosorbide dinitrate remaining.
- Example 11 The preparative methodology used was as described in Example 11 above. While maintaining the 1.75 molar equivalent level of sodium tetrahydroborate used (as outlined in Example 2 of Table 6 above) the iron phthalocyanine molar equivalent level was reduced from 0.0623 molar equivalents (as outlined in Example 2 of Table 6 above) to 0.0312 molar equivalents (run 2 of Table 7 below), then to 0.0125 molar equivalents (run 3 of Table 7 below), and finally to 0.0062 molar equivalents (run 4 of Table 7 below) .
- dichloromethane/methanol solvent system is the desired combination, since once can utilise lower sodium tetrahydroborate and iron phthalocyanine molar equivalent levels to achieve a good yield and selectivity of isosorbide-5- mononitrate from isosorbide dinitrate, when compared with the equivalent solvent system of dichloromethane/ethanol.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9930778 | 1999-12-29 | ||
GBGB9930778.7A GB9930778D0 (en) | 1999-12-29 | 1999-12-29 | Compound synthesis |
PCT/GB2000/004996 WO2001049692A1 (en) | 1999-12-29 | 2000-12-28 | Synthesis of isorsorbide mononitrate |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1248788A1 true EP1248788A1 (en) | 2002-10-16 |
EP1248788B1 EP1248788B1 (en) | 2004-10-27 |
Family
ID=10867135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20000985697 Expired - Lifetime EP1248788B1 (en) | 1999-12-29 | 2000-12-28 | Synthesis of isosorbide mononitrate |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1248788B1 (en) |
JP (1) | JP2003519235A (en) |
AT (1) | ATE280771T1 (en) |
AU (1) | AU2209601A (en) |
DE (1) | DE60015396D1 (en) |
GB (1) | GB9930778D0 (en) |
WO (1) | WO2001049692A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103641840B (en) * | 2013-11-28 | 2016-03-16 | 青岛黄海制药有限责任公司 | A kind of synthesis of 5-isosorbide mononitrate and purification process |
CN104892623B (en) * | 2015-06-11 | 2017-08-11 | 山东新时代药业有限公司 | A kind of preparation method of 5 Isosorbide Mononitrate |
CN109369754B (en) * | 2018-09-30 | 2022-03-01 | 镇江利众医药科技有限公司 | Nitrate ester compound and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2500835A1 (en) * | 1981-02-27 | 1982-09-03 | Poudres & Explosifs Ste Nale | PROCESS FOR THE SYNTHESIS OF MONONITRATES OF ISOSORBIDE |
IT1208537B (en) * | 1985-05-10 | 1989-07-10 | Consiglio Nazionale Ricerche | PROCESS FOR THE PREPARATION OF ISOSORBIDE-5-MONOHYDRATE. |
IT1311986B1 (en) * | 1999-03-26 | 2002-03-22 | Dinamite Dipharma S P A In For | PROCEDURE FOR THE PREPARATION OF NITRICAL MONOESTERS OF HYDROXIALKYL COMPOSTIDES AND DIHYDROXYCLOCALKYLS. |
-
1999
- 1999-12-29 GB GBGB9930778.7A patent/GB9930778D0/en not_active Ceased
-
2000
- 2000-12-28 AU AU22096/01A patent/AU2209601A/en not_active Abandoned
- 2000-12-28 DE DE60015396T patent/DE60015396D1/en not_active Expired - Lifetime
- 2000-12-28 WO PCT/GB2000/004996 patent/WO2001049692A1/en active IP Right Grant
- 2000-12-28 EP EP20000985697 patent/EP1248788B1/en not_active Expired - Lifetime
- 2000-12-28 AT AT00985697T patent/ATE280771T1/en not_active IP Right Cessation
- 2000-12-28 JP JP2001550232A patent/JP2003519235A/en active Pending
Non-Patent Citations (1)
Title |
---|
See references of WO0149692A1 * |
Also Published As
Publication number | Publication date |
---|---|
ATE280771T1 (en) | 2004-11-15 |
AU2209601A (en) | 2001-07-16 |
WO2001049692A1 (en) | 2001-07-12 |
JP2003519235A (en) | 2003-06-17 |
EP1248788B1 (en) | 2004-10-27 |
GB9930778D0 (en) | 2000-02-16 |
DE60015396D1 (en) | 2004-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100298582A1 (en) | Intermediate Compounds and Processes for the Preparation of 7-benzyloxy-3-(4-methoxyphenyl)-2H-1-benzopyran | |
EP1860103A1 (en) | Anticancer compound, intermediate therefor, and processes for producing these | |
CN114315849B (en) | Method for preparing 2-indole perhydrofuran [2,3-b ] benzopyran | |
Passiniemi et al. | Asymmetric synthesis of pachastrissamine (jaspine B) and its diastereomers via η 3-allylpalladium intermediates | |
Majumdar et al. | Synthesis of five-and six-membered heterocyclic compounds by the application of the metathesis reactions | |
AU2002241764A1 (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof | |
EP1248788B1 (en) | Synthesis of isosorbide mononitrate | |
JP2025072517A (en) | Method for producing phenol derivatives | |
AU2002365874A1 (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof | |
IE52602B1 (en) | Process for the synthesis of isosorbide mononitrates | |
KR100980379B1 (en) | Method for preparing 5-hydroxy-3-oxoheptanoate derivative having optical activity | |
EP2376469B1 (en) | Method for preparing (3s,4s)-4-((r)-2-(benzyloxy)tridecyl)-3-hexyl-2-oxetanone and novel intermediate used therefor | |
Farin et al. | Pseudoesters and derivatives. XXVI. Formation of cyclopropanes and five membered heterocycles by Michael initiated ring closure reactions of 2-bromo-3-formylacrylic acid derivatives | |
CN115716799A (en) | Method for preparing cis-chiral-3-fluoro-4-hydroxypiperidine and derivatives thereof by reduction of organic borohydride metal reagent | |
Wang et al. | A Synthesis of Substituted 3, 6-Dihydro-1H-benzo (c) oxocines via Claisen Rearrangement and Ring-closing Metathesis | |
EP1741716B1 (en) | Process for producing pentacyclic taxane | |
CN117677597A (en) | Hydrogenation of esters to alcohols in the presence of Mn-PNN complexes | |
JP2007084536A (en) | Method for producing procyanidins B1-B4 and catechin polymers | |
CN111793047B (en) | Preparation method of eribulin intermediate | |
CN109485661B (en) | [3+2] Cycloaddition Synthesis of Benzazolooxazoles | |
CA2902009A1 (en) | Isohexide monotriflates and process for synthesis thereof | |
Dardennes et al. | Diastereoselective trimolecular condensation between indole, Meldrum’s acid and chiral sugar-derived aldehydes | |
GB2358859A (en) | Synthesis of isosorbide compounds | |
Pitsch et al. | Synthesis of a functionalized cyclohepten-one from erythronic acid-4-lactone | |
CN119431211A (en) | An intermediate and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020718 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20041027 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20041027 Ref country code: CH Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20041027 Ref country code: FR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20041027 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20041027 Ref country code: LI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20041027 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20041027 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20041027 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20041027 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20041027 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20041027 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 60015396 Country of ref document: DE Date of ref document: 20041202 Kind code of ref document: P |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20041228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20041230 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20041231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050127 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050127 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050128 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050207 |
|
LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20041027 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
26N | No opposition filed |
Effective date: 20050728 |
|
EN | Fr: translation not filed | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20061220 Year of fee payment: 7 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20050327 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20071228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071228 |